Pascal and Francis Bibliographic Databases

Help

Search results

Your search

ti.\*:("How Drugs may Work to Better Protect the Gastrointestinal Tract: Mechanisms Involved in Gastrointestinal Tract Protection")

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 19 of 19

  • Page / 1
Export

Selection :

  • and

Antimicrobial Peptides and ColitisHO, Samantha; POTHOULAKIS, Charalabos; HON WAI KOON et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 40-47, issn 1381-6128, 8 p.Article

Taming the Irritable BowelWOOD, Jackie D.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 142-156, issn 1381-6128, 15 p.Article

How Drugs may Work to Better Protect the Gastrointestinal Tract: Mechanisms Involved in Gastrointestinal Tract ProtectionSIKIRIC, Predrag.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, issn 1381-6128, 161 p.Serial Issue

Gastroprotective Role of Glucocorticoids During NSAID-induced GastropathyFILARETOVA, Ludmila.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 29-33, issn 1381-6128, 5 p.Article

Gastric Mucosal Protection And Central Nervous SystemGYIRES, Klara; NEMETH, József; ZADORI, Zoltan S et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 34-39, issn 1381-6128, 6 p.Article

Novel Pharmacologic Approaches to the Prevention and Treatment of Ulcerative ColitisXIAOMING DENG; SZABO, Sandor; KHOMENKO, Tetyana et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 17-28, issn 1381-6128, 12 p.Article

Chemoprevention of Cancers in Gastrointestinal Tract with Cyclooxygenase 2 InhibitorsRUI WANG; LINJIE GUO; PU WANG et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 115-125, issn 1381-6128, 11 p.Article

Target-oriented Mechanisms of Novel Herbal Therapeutics in the Chemotherapy of Gastrointestinal Cancer and InflammationKO, Joshua K; AUYEUNG, Kathy K.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 48-66, issn 1381-6128, 19 p.Article

Novel Possible Pharmaceutical Research Tools: Stem Cells, Gene Delivery and their CombinationVARGA, Gabor; BORI, Erzsebet; KALLO, Karola et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 133-141, issn 1381-6128, 9 p.Article

The Impact of Asymmetric Dimethylarginine (ADAMA), the Endogenous Nitric Oxide (NO) Synthase Inhibitor, to the Pathogenesis of Gastric Mucosal DamageSZLACHCIC, Aleksandra; KRZYSIEK-MACZKA, Gracjana; PAJDO, Robert et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 90-97, issn 1381-6128, 8 p.Article

Irsogladine: Overview of the Mechanisms of Mucosal Protective and Healing-Promoting Actions in the Gastrointestinal TractAKAGI, Michiyo; AMAGASE, Kikuko; MURAKAMI, Toshiko et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 106-114, issn 1381-6128, 9 p.Article

Nicotine and Gastrointestinal Disorders: Its Role in Ulceration and Cancer DevelopmentCHU, Kent-Man; CHO, Chi H; SHIN, Vivian Y et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 5-10, issn 1381-6128, 6 p.Article

Discovery of Lansoprazole and its Unique Pharmacological Properties Independent from Anti-secretory ActivitySATOH, Hiroshi.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 67-75, issn 1381-6128, 9 p.Article

Role of Nitric Oxide in the Central Interferon-alpha-induced Inhibition of Gastric Acid Secretion in RatsCZIMMER, József; KIRALY, Agnes; LASZLO SZABO, Imre et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 11-16, issn 1381-6128, 6 p.Article

Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157SIKIRIC, Predrag; SEIWERTH, Sven; ILIC, Spomenko et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 76-83, issn 1381-6128, 8 p.Article

Gastric Cytoprotection Beyond Prostaglandins: Cellular and Molecular Mechanisms of Gastroprotective and Ulcer Healing Actions of AntacidsTARNAWSKI, Andrzej; AHLUWALIA, Amrita; JONES, Michael K et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 126-132, issn 1381-6128, 7 p.Article

Sulforaphane Protects Small Intestinal Mucosa From Aspirin/NSAID-Induced Injury by Enhancing Host Defense Systems Against Oxidative Stress and by Inhibiting Mucosal Invasion of Anaerobic EnterobacteriaYANAKA, Akinori; SATO, Junya; OHMORI, Shun et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 157-162, issn 1381-6128, 6 p.Article

Molecular Pharmacological Approaches to Effects of Capsaicinoids and of Classical Antisecretory Drugs on Gastric Basal Acid Secretion and on Indomethacin-Induced Gastric Mucosal Damage in Human Healthy Subjects (Mini Review)LASZLO SZABO, Imre; CZIMMER, József; SZOLCSANYI, Janos et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 84-89, issn 1381-6128, 6 p.Article

Central Actions of Somatostatin-28 and Oligosomatostatin Agonists to Prevent Components of the Endocrine, Autonomic and Visceral Responses to Stress Through Interaction with Different Somatostatin Receptor SubtypesSTENGEL, Andreas; RIVIER, Jean; TACHE, Yvette et al.Current pharmaceutical design (Print). 2013, Vol 19, Num 1, pp 98-105, issn 1381-6128, 8 p.Article

  • Page / 1